From: Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
 | Healthy volunteers | Sepsis | CTS-TXA | Cirrhotic liver disease | Pregnancy |
---|---|---|---|---|---|
Hb (mmol/L) | 9.0 (8.4–9.6) | 6.0* (5.6–6.3) | 6.2* (5.7–6.7) | 7.7* (7.2–8.4) | 7.8* (7.0–8.4) |
Ht (L/L) | 0.43 (0.40–0.45) | 0.29* (0.27–0.31) | 0.29* (0.26–0.32) | 0.38* (0.34–0.39) | 0.36* (0.34–0.39) |
PLT (x109/L) | 178 (139–212) | 141 (95–213) | 101* (91–140) | 99* (62–136) | 202 (127–234) |
WBC (x109/L) | 6.4 (5.4–7.9) | 20.1* (11.5–25.3) | 10.7* (8.3–12.4) | 5.0 (4.0–7.5) | 10.7* (9.3–11.7) |
PT (s) | 10.5 (10.2–10.8) | 11.5* (10.7–12.1) | 11.8* (11.5–12.4) | 13.3* (13.0–13.5) | 9.6* (9.3–9.6) |
aPTT (s) | 27 (26–27) | 33.5* (30–42.5) | 30* (28–33) | 29* (29–34) | 25* (23–25) |